Dr. Christopher Laohathai, MD

Dr. Laohathai practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Laohathai's NPI, 1821309279, was assigned on June 30, 2010. Dr. Laohathai holds Missouri license 2014030572.

Dr. Laohathai's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Laohathai's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Laohathai to 1 more behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laohathai practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Laohathai's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Laohathai is licensed in Missouri.

CMS data shows 300 Medicare services from Dr. Laohathai across 7 procedure codes in 2024, for 138 Medicare patients. Medicare paid $34,775 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Laohathai in 2024. The largest group is under 65, with 61 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Laohathai's median patient age at 63, with 52% women.

In 2024, Dr. Laohathai wrote 1,223 Medicare Part D claims for 108 patients. 81% of them were for generic drugs. CMS names the drug for 1,111 of them, across 26 drugs with 11 or more claims each, at $372,511 in total drug cost. In 2023, CMS named 930 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Laohathai for performance year 2024, reported as part of a group. Dr. Laohathai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Laohathai from 2 drug and device companies in 2017. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $68.